Back to results
US 12,496,333 B2Granted
Vaccine compositions comprising C-C motif chemokine 22 (CCL22) or fragments thereof
AssigneeIO Biotech ApS
InventorMads Hald Andersen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to CCL22 as a T cell target in cancer immunosuppression.
Claims14
A nucleic acid encoding an immunogenically active CCL22 peptide fragment consisting of at the most 50 consecutive residues of SEQ ID NO:
- 12, wherein said peptide fragment is of at least 25 amino acids and contains a sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, and SEQ ID NO:
- 11.
3 more elements
Dependencies are inferred from the claim text.